Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
äŒæ¥ã³ãŒãBNR
äŒç€ŸåBurning Rock Biotech Ltd
äžå Žæ¥Jun 12, 2020
æé«çµå¶è²¬ä»»è
ãCEOãHan (Yusheng)
åŸæ¥å¡æ°674
蚌åžçš®é¡Depository Receipt
æ±ºç®ææ«Jun 12
æ¬ç€Ÿæåšå°No. 5 Xingdao Ring Road North
éœåžGUANGZHOU
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœChina
éµäŸ¿çªå·510005
é»è©±çªå·
ãŠã§ããµã€ãhttps://www.brbiotech.com/
äŒæ¥ã³ãŒãBNR
äžå Žæ¥Jun 12, 2020
æé«çµå¶è²¬ä»»è
ãCEOãHan (Yusheng)